AzTrials
AzTrials

HIV (Human Immunodeficiency Virus)TMP ProjectNCT07088770

TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry

A study testing Community Coalition CLS Workgroup/Network of Providers, Tech-mediated Training and Service Delivery and Multidisciplinary Implementation Team with Champion in people with HIV (Human Immunodeficiency Virus) and Substance Abuse Disorder, run by Columbia University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical study in one NY county is to pilot and refine implementation strategies aimed at improving delivery and uptake of evidence-based practices (EBPs) for HIV prevention/treatment and substance use disorder (SUD) care among incarcerated individuals approaching release with or at risk for HIV and… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Community Coalition CLS Workgroup/Network of Providers, Tech-mediated Training and Service Delivery and Multidisciplinary Implementation Team with Champion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
65 participants
Where
1 siteUnited States
Study dates
22 Nov 2024to 30 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥18 years old
  • speaks and understands English
  • report using any illicit drug, in the six months prior to incarceration
  • report having had condomless receptive and/or insertive vaginal and/or anal sex without either condom use, AND/OR report another HIV risk in the six months prior to incarceration (i.e. shared syringes, STI+)D
  • likely to be released in the next 1-3 months

Who cannot join

  • evidence of significant psychiatric or cognitive impairment that would limit effective participation as confirmed during informed consent assessed during informed consent or confirmed by the MacArthur Competence Assessment Tool
  • not fluent in English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Ulster County Jail

    Kingston, New York, 12401

Other trials in United States

About this study

Official title: TechMPower: Advancing HIV/SUD Care and Service Delivery for People Involved in the Criminal Legal System

The goal of this clinical study in one NY county is to pilot and refine implementation strategies aimed at improving delivery and uptake of evidence-based practices (EBPs) for HIV prevention/treatment and substance use disorder (SUD) care among incarcerated individuals approaching release with or at risk for HIV and SUD.

The main questions it aims to answer are:

Read more
  1. How feasible and acceptable are the TechMPower implementation strategies (community coalition workgroups, multidisciplinary implementation team with champion, and tech-mediated training/service delivery with peer navigation) in real-world carceral and reentry settings?
  2. To what extent do these strategies improve delivery and uptake of HIV testing with self-testing (HST), pre-exposure prophylaxis (PrEP)/antiretroviral treatment (ART), medications for opioids use disorder (MOUD), and overdose education and naloxone distribution (OEND)?
  3. What are the preliminary cost estimates for the implementation strategies and EBPs to inform the larger trial to follow in NY and NJ?
  4. What are the preliminary impacts on individual-level outcomes such as HIV testing, linkage to care, and SUD treatment initiation?

Our specific aims for the Phase I protocol presented here is conducted in one county (Ulster County) with a sample (n=50) of detained (prisoners) in their county jail are presented here:

  • R61 | Aim 1: Evaluate \ preliminary effectiveness of TechMPower, using mixed methods and a pre-/post-evaluation design, on increasing reach of the EBPs resulting in the following outcomes: (1) SUD and HIV screenings (pre-/post-release); and (2) linkage to SUD prevention/care (MOUD, OEND); and (3) linkage to HIV prevention/care (applying a status-neutral approach) with community service providers post-release. (Effectiveness).
  • R61 | Aim 2: Identify how adoption/feasibility, implementation/fidelity and sustainability/maintenance of TechMPower may impact effectiveness of TechMPower outcomes as described in Aim 1 in one (Ulster County) jail using surveys of Implementation Team, jail staff and other key stakeholders. (Implementation)
  • R61 | Aim 3: Use implementation mapping to adapt implementation strategies for R33 phase. (Implementation)
Read the detailed description

HIV prevalence in correctional facilities in the US is about five times greater than in the general population and about 14% of people living with HIV (PLWH) experience incarceration/release every year and 15% of those incarcerated do not know their HIV status. Over 50,000 people are incarcerated in New York state and 1-2% are estimated to be PLWH. Similarly, substance use disorder (SUD) is highly prevalent among criminal-legal system (CLS)-involved people, with an estimated 70-80% of US jail detainees having a SUD are at high risk of relapse, overdose-related mortality and HIV infection post-release. Intervening during incarceration provides an opportunity to address HIV care in hard-to-reach individuals, though more robust interventions and staff training is needed to improve care continuity. Increasing point-of-care rapid testing would maximize HIV detection and results receipt among people in jails, and prepare them with needed knowledge and skills post-release.

To fill this gap, the investigators propose a Regional Research Hub (RRH) and 2-phase, Hybrid Type II effectiveness/implementation study to evaluate the effectiveness of TechMPower, an intervention that bundles implementation strategies to increase delivery of evidence-based intervention (EBPs) to prevent adverse HIV-related (new infection, untreated HIV) and SUD-related outcomes (fatal and non-fatal overdose) among a sample of individuals (n=1200) in 6 New York and New Jersey State County jails. In the first phase submitted in this IRB protocol, the researchers will pilot TechMPower to prepare for the phase two full R33 trial, informed by PRISM/RE-AIM and the health equity framework, by recruiting in one NYS county jail (n=50) and an existing HEALing Communities Study coalition workgroup to evaluate the training on and implementation of the selected EBPs required as standard of care in jails. This record contains the R61 pilot portion.

Researchers will compare outcomes before and after implementation of the strategy bundle to see if TechMPower improves reach, adoption, implementation fidelity, and sustainability of integrated HIV/SUD services.

Participants incarcerated (N=50) will:

  1. Complete baseline and 3-month follow-up surveys on HIV/SUD behaviors and care engagement
  2. Participate in up to 60-minute qualitative interviews (subset N=8)
  3. Receive potential HIV/STI testing, referrals to prevention/treatment, and linkage services including peer navigation enhanced case management (NCM)
  4. Receive HIV self-test kit and Naloxone upon release

Stakeholder participants (N=20) will:

  1. Complete baseline and 3-month follow-up surveys on HIV/SUD behaviors and care engagement
  2. Participate in up to 60-minute qualitative interviews (subset N=8)
  3. Receive training in HIV and SUD screening and treatment referral (SBIRT), HST and OEND, person-centered approach to care linkage; tech-mediated training and service delivery; and in NCM
  4. Participate in coalition workgroup, implementation team and implementation of NCM
Being tested
Community Coalition CLS Workgroup/Network of Providers, Tech-mediated Training and Service Delivery, Multidisciplinary Implementation Team with Champion, Tech-mediated Peer Navigation Enhanced Case management (NCM)
Keywords
People incarcerated in re-entry, HIV testing, Screening, brief intervention, and referral to treatment, Implementation strategies, Implementation team with champion, Navigation case management, Coalition, Techmediated
Medical subject headings
Acquired Immunodeficiency Syndrome, Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Community Coalition CLS Workgroup/Network of ProvidersBehavioural

    Community Coalition/Network of Providers TechMPower forms the foundation of community engagement in this approach, with membership including PLWH and SUD, sheriffs, within-jail staff, community service providers or other partners who are able to advance the adoption of EBPs within jail and service settings. All coalitions are trained and prepared to drive a planning process at the local level for efficient identification and allocation of resources needed to link people from CLS to a network of community providers for HIV and SUD care and retention. Community coalitions integrate evidence-based (ERIC) strategies: Build coalition; Promote network weaving; Identify/train champions; Conduct consensus discussions that support needed services.

  • Tech-mediated Training and Service DeliveryBehavioural

    Researchers will train all staff, healthcare providers and peer navigators to recognize and reduce stigma in CLS and healthcare settings using a training program informed by MPI Frye and colleagues in the CHHANGE (MH102182-01) intervention, which developed an anti-intersectional stigma training program for CBOs and offers comprehensive training to healthcare and social service organizations. Additionally, researchers will train staff and support protocol enhancements as needed to utilize tech mediated service delivery for NCM in-reach and services coordination in the community. These integrate 5 evidence-based (ERIC) implementation strategies: promote consultation; provide clinical/technical supervision; centralize technical assistance; change physical structure and equipment.

  • Multidisciplinary Implementation Team with ChampionBehavioural

    The multidisciplinary Implementation Team will be comprised of a correctional health nurse, social worker and discharge planner or counselor and corrections officer from the jail. A representative from the community coalition and peer and case manager from NCM will join the team using a tech-mediated platform for conducting the training and for on-going weekly case conferencing addressing system and client level barriers and service planning. The role of the champion from the correctional setting will be to convene meetings focused on fidelity to the intervention components, engagement in shared problem-solving and mediation of administrative issues that may inhibit effective implementation of TechMPower. The champion and implementation team may request technical assistance (TA) or implementation facilitation at any point during implementation. This TA may be provided by the investigative team or outside providers from federal programs.

  • Tech-mediated Peer Navigation Enhanced Case management (NCM)Behavioural

    Navigation-Enhanced Case Management (NCM) uses Project START, a CDC best evidence intervention as its HIV risk reduction framework. Prior to release, a case manager and peer navigator via telehealth and in-person provide discharge planning and patient education and serves as a liaison to the courts. After release, patient navigators facilitate reentry into community care and provide referrals to HIV medical and SUD care as appropriate (e.g., ART, PrEP, MOUD) and assistance with food, housing, transportation, employment, substance dependence, mental health treatment, and legal issues. TechMPower planned to enhance tracking of linkage during NCM services by integrating reporting along with a web-based platform that tracks assignment of providers and peers and follows for 6 months to capture PRISM linkage and retention in MOUD, HIV and ancillary care.

Study groups in NCT07088770
Study groupRoleWhat they receive
TechMPower Implementation StrategiesExperimentalTechMPower applies evidence-based Implementation Strategies, including: A) data-driven, Community Coalitions and criminal legal system (CLS) focused workgroup informed by the HEALing Communities Study (HCS) Communities That HEAL(CTH intervention); B) Implementation Team led by champions; C) training on optimal person-centered service delivery for service providers/organizations; and D) tech-mediated service delivery, technical assistance, and training to increase: 1) HIV screening/testing via self-testing; 2) SUD screening, brief interview and referral to treatment (SBIRT); and 3) access to and uptake of biomedical HIV and SUD prevention and treatment (PrEP/PEP/ART); overdose education/naloxone distribution [OEND], opioid use disorder medication [MOUD]) delivered through 4) hybrid linkage (telehealth, face-to-face) to services via Navigation Enhanced Case Management (NCM).
Receives: Behavioral: Community Coalition CLS Workgroup/Network of Providers; Behavioral: Tech-mediated Training and Service Delivery; Behavioral: Multidisciplinary Implementation Team with Champion; Behavioral: Tech-mediated Peer Navigation Enhanced Case management (NCM)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of people incarcerated who have received an HIV test

    This is to measure HIV testing (including self-testing) at jail. The number of participants that report in survey at least 1 testing will be tallied. Aggregate reporting on testing from facility will be captured for triangulation.

    Measured: Baseline and 3 months follow-up

  2. Number of people detained screened for SBIRT

    This is to measure the feasibility, efficacy of Screening, Brief Intervention and Referral to treatment (SBIRT) for SUD at jail. The number of participants that report in survey receiving SBIRT will be tallied. Aggregate reporting on SBIRT from facility will be captured for triangulation.

    Measured: Baseline and 3 months follow-up

  3. HIV care access & utilization/ART Use/adherence/viral load/CD4 count

    Service Use Measure: at least one visit to HIV-focused medical at clinic post release. The number of participants that report in surveys receiving HIV treatment will be tallied. Aggregate reporting on HIV treatment from facility referrals will be captured for triangulation.

    Measured: 3-month following pos test result, pre- post release

  4. Average PrEP oral daily/injectable/episodic PrEP captured in records/chart review; ACASI self-report

    This is to measure PrEP use, adherence \& discontinuation

    Measured: Baseline and 3 months follow-up

  5. PEP uptake rate

    This is to measure PEP use by seeing the uptake: starter pack \& full treatment provision/fulfillment and adherence, PEP to PrEP transition

    Measured: Baseline and 3 months follow-up

Secondary outcomes (3)
  1. Number of clients referred and assessed for NCM

    This is to measure the feasibility of Navigation Enhanced Case Management (NCM). The number of participants that report in survey receiving NCM will be tallied. Aggregate reporting on NCM service delivery will be captured for triangulation.

    Measured: Baseline and 6 months

  2. Number of people incarcerated receiving OEND

    This is to measure the Overdose education and Naloxone Distribution (OEND) feasibility at jail. The number of participants that report in survey receiving OEND will be tallied. Aggregate reporting on OEND service delivery from facility will be captured for triangulation.

    Measured: Baseline and 3 months follow-up

  3. Number of staff receiving training on TechMPower integrated SUD/HIV service delivery

    This is to measure the feasibility of TechMPower techmediated training and HIV/SUD integrated service delivery. This is reported on surveys and aggregate reporting on techmediated training attendance logs for triangulation.

    Measured: Baseline and 6 months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2025
  2. Study start22 Nov 2024
  3. Primary completion30 Sep 2025
  4. Study completion30 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
TechMPower, informed by PRISM1/RE-AIM implementation science framework, is an intervention that bundles implementation strategies for correctional settings designed to increase delivery of evidence-based practices (EBPs) to prevent adverse HIV-related (new infections, untreated HIV) and SUD-related outcomes (fatal and non-fatal overdose) among individuals detained in jails and reentering the community. The selected EBPs act to increase: 1) HIV screening via universal rapid point-of-care ( POC) testing (policy/practice change in some jail settings) and self-testing education (WHO universal testing/self-testing; 2) Substance Use Disorder (SUD) screening (via universal SBIRT); and 3) linkage to HIV and SUD care/prevention services supported by Navigation Enhanced Case Management (NCM) using hybrid communication (telehealth/tele-harm reduction, video-conference, face-to-face, text/SMS, etc.) approaches.
Masking
None (open label)
Enrolment
65 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07088770
Sponsor's protocol ID
AAAV1468
Other IDs
1R61DA060620-01
Acronym
TMP Project
Status last verified
Feb 2026
First submitted
19 Jul 2025
Last updated
18 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Protecting data from people incarcerated (prisoners) is of the utmost importance.

Questions about this trial

What is this clinical trial studying?

A study testing Community Coalition CLS Workgroup/Network of Providers, Tech-mediated Training and Service Delivery and Multidisciplinary Implementation Team with Champion in people with HIV (Human Immunodeficiency Virus) and Substance Abuse Disorder, run by Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of people incarcerated who have received an HIV test (time frame: Baseline and 3 months follow-up). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in